Pruszczyk, Piotr; Klok, Frederikus A.; Kucher, Nils et al.
Percutaneous treatment options for acute pulmonary embolism: a clinical consensus statement by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function and the European Association of Percutaneous Cardiovascular InterventionsEUROINTERVENTION. Bd. 18. H. 8. 2022 S. 623-638
Farmakis, Ioannis T.; Barco, Stefano; Mavromanoli, Anna C. et al.
Performance Status and Long-Term Outcomes in Cancer-Associated Pulmonary Embolism Insights From the Hokusai-VTE Cancer StudyJACC: CARDIOONCOLOGY. Bd. 4. H. 4. 2022 S. 507-518
Lindhoff-Last, Edelgard; Birschmann, Ingvild; Bidenharn, Antonia J. et al.
Pharmacokinetics of Phenprocoumon in Emergency Situations-Results of the Prospective Observational RADOA-Registry (Reversal Agent Use in Patients Treated with Direct Oral Anticoagulants or Vitamin K Antagonists Registry)PHARMACEUTICALS. Bd. 15. H. 11. 2022
Zhang, Wenjun; Wan, Mengwen; Gao, Kun et al.
Pharmacologic IRE1 alpha kinase inhibition alleviates aortic dissection by decreasing vascular smooth muscle cells apoptosisINTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES. Bd. 18. H. 3. 2022 S. 1053-1064
Bauersachs, Rupert; Klingenheben, Thomas
Pharmacotherapy - Coagulation and antithrombotic TherapyAKTUELLE KARDIOLOGIE. Bd. 11. H. 06. 2022 S. 505-505
Greinacher, Andreas; Langer, Florian; Schoenborn, Linda et al.
Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathyHAEMATOLOGICA. Bd. 107. H. 5. 2022 S. 1219-1221
Wolf, Simon; Spirk, David; Forgo, Gabor et al.
Prevalent use of high-intensity statin therapy and LDL-C target attainment among PAD patients undergoing angioplasty A single-center retrospective cross-sectional analysisVASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE. Bd. 51. H. 6. 2022 S. 357-364
Berkowitz, Scott D.; Bauersachs, Rupert M.; Szarek, Michael et al.
Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy aloneJOURNAL OF THROMBOSIS AND HAEMOSTASIS. Bd. 20. H. 5. 2022 S. 1193-1205
Luo, Qi; Wenzel, Philip
Properdin (factor P) as a new target cleaved by factor XIa: Intrinsic coagulation at the crossroads with inflammationRESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS. Bd. 6. H. 7. 2022
Fleischer, Maria Isabel; Roehrig, Nadine; Raker, Verena K. et al.
Protease- and cell type-specific activation of protease-activated receptor 2 in cutaneous inflammationJOURNAL OF THROMBOSIS AND HAEMOSTASIS. Bd. 20. H. 12. 2022 S. 2823-2836